Sandbox Reserved 1794
From Proteopedia
(Difference between revisions)
Line 47: | Line 47: | ||
== HBV Binding and Infection== | == HBV Binding and Infection== | ||
- | NTCP is the only [https://rupress.org/jcb/article/195/7/1071/54877/The-cell-biology-of-receptor-mediated-virus entry receptor] <Ref name = "Grove"> Grove, J.; Marsh, M. The Cell Biology of Receptor-Mediated Virus Entry. Journal of Cell Biology 2011, 195 (7), 1071–1082. </ref> into the liver for HBV and HDV. <Ref name = "Asami"/>These viruses are known to use <scene name='95/952721/Hep_patches/2'>two different patches</scene> <font color='#00e080'><b>(residues 84-87 and 157-165)</b></font> on NTCP for binding and entry. The [https://en.wikipedia.org/wiki/Myristoylation myristolated] PreS1 domain of HBV binds to NTCP through the <scene name='95/952721/Hbv_patch_1/1'>first hydrophobic patch</scene> on NTCP containing <font color='#00e080'><b>residues 157-165</b></font> on the open pore surface. <Ref name = "Asami"/> These residues form part of the bile salt transport tunnel resulting in HBV binding and bile salt transport directly competing and interfering with one another. <Ref name = "Asami"/> The <scene name='95/952721/Hbv_patch_2/1'>other hydrophobic patch</scene> consisting of <font color='#00e080'><b>residues 84-87</b></font> found on the N-terminus of NTCP does not overlap with bile salt binding and may be used for the development of [https://en.wikipedia.org/wiki/Antiviral_drug antivirals] that do not inhibit bile uptake <Ref name = "Park"/>. Other minor variations within NTCP provide species specificity for HBV or virus resistance, such as mutant S267F found in East Asia. <Ref name = "Park"/> This S267F mutation is a [https://en.wikipedia.org/wiki/Single-nucleotide_polymorphism single-nucleotide polymorphism], where a change in one nucleotide in the sequence has caused a lack of bile salt transport activity or viral infection. <Ref name = "Park"/> It is hypothesized that due to the lack of bile salt transport in this mutation that | + | NTCP is the only [https://rupress.org/jcb/article/195/7/1071/54877/The-cell-biology-of-receptor-mediated-virus entry receptor] <Ref name = "Grove"> Grove, J.; Marsh, M. The Cell Biology of Receptor-Mediated Virus Entry. Journal of Cell Biology 2011, 195 (7), 1071–1082. </ref> into the liver for HBV and HDV. <Ref name = "Asami"/>These viruses are known to use <scene name='95/952721/Hep_patches/2'>two different patches</scene> <font color='#00e080'><b>(residues 84-87 and 157-165)</b></font> on NTCP for binding and entry. The [https://en.wikipedia.org/wiki/Myristoylation myristolated] PreS1 domain of HBV binds to NTCP through the <scene name='95/952721/Hbv_patch_1/1'>first hydrophobic patch</scene> on NTCP containing <font color='#00e080'><b>residues 157-165</b></font> on the open pore surface. <Ref name = "Asami"/> These residues form part of the bile salt transport tunnel resulting in HBV binding and bile salt transport directly competing and interfering with one another. <Ref name = "Asami"/> The <scene name='95/952721/Hbv_patch_2/1'>other hydrophobic patch</scene> consisting of <font color='#00e080'><b>residues 84-87</b></font> found on the N-terminus of NTCP does not overlap with bile salt binding and may be used for the development of [https://en.wikipedia.org/wiki/Antiviral_drug antivirals] that do not inhibit bile uptake <Ref name = "Park"/>. Other minor variations within NTCP provide species specificity for HBV or virus resistance, such as mutant S267F found in East Asia. <Ref name = "Park"/> This S267F mutation is a [https://en.wikipedia.org/wiki/Single-nucleotide_polymorphism single-nucleotide polymorphism], where a change in one nucleotide in the sequence has caused a lack of bile salt transport activity or viral infection. <Ref name = "Park"/> It is hypothesized that due to the lack of bile salt transport in this mutation that the open-pore state during bile salt transport is necessary for HBV and HDV infection, suggesting the two functionally overlap. <Ref name = "Park"/> |
The exact mechanism by which NTCP mediates viral internalization is still being determined; however, current evidence suggests it works through [https://en.wikipedia.org/wiki/Viral_entry#Entry_via_endocytosis endocytosis.] <Ref name = "Herrscher"> Herrscher C, Roingeard P, Blanchard E. Hepatitis B Virus Entry into Cells. Cells. 2020 Jun 18;9(6):1486. doi: 10.3390/cells9061486. PMID: 32570893; PMCID: PMC7349259. </ref> Once HBV is bound, the NTCP/HBV complex is taken into the cell where viral contents are dumped into the cytoplasm to then begin [https://en.wikipedia.org/wiki/Viral_replication viral replication]. HBV may also interact with other receptors or host cell factors, as cells overexpressing NTCP alone had low infection efficiency. <Ref name = "Herrscher"/> | The exact mechanism by which NTCP mediates viral internalization is still being determined; however, current evidence suggests it works through [https://en.wikipedia.org/wiki/Viral_entry#Entry_via_endocytosis endocytosis.] <Ref name = "Herrscher"> Herrscher C, Roingeard P, Blanchard E. Hepatitis B Virus Entry into Cells. Cells. 2020 Jun 18;9(6):1486. doi: 10.3390/cells9061486. PMID: 32570893; PMCID: PMC7349259. </ref> Once HBV is bound, the NTCP/HBV complex is taken into the cell where viral contents are dumped into the cytoplasm to then begin [https://en.wikipedia.org/wiki/Viral_replication viral replication]. HBV may also interact with other receptors or host cell factors, as cells overexpressing NTCP alone had low infection efficiency. <Ref name = "Herrscher"/> |
Revision as of 21:42, 20 April 2023
Contents |
Sodium Taurocholate Co-Transporting Polypeptide
|
References
- ↑ Stieger B. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. Handb Exp Pharmacol. 2011;(201):205-59. doi: 10.1007/978-3-642-14541-4_5. PMID: 21103971. DOI: DOI: 10.1007/978-3-642-14541-4_5.
- ↑ Geyer, J., Wilke, T. & Petzinger, E. The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships. Naunyn Schmied Arch Pharmacol 372, 413–431 (2006). https://doi.org/10.1007/s00210-006-0043-8
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 Goutam, K., Ielasi, F.S., Pardon, E. et al. Structural basis of sodium-dependent bile salt uptake into the liver. Nature 606, 1015–1020 (2022). DOI: 10.1038/s41586-022-04723-z.
- ↑ 4.0 4.1 4.2 4.3 4.4 Park, JH., Iwamoto, M., Yun, JH. et al. Structural insights into the HBV receptor and bile acid transporter NTCP. Nature 606, 1027–1031 (2022). https://doi.org/10.1038/s41586-022-04857-0.
- ↑ 5.0 5.1 5.2 5.3 5.4 Liu, H., Irobalieva, R.N., Bang-Sørensen, R. et al. Structure of human NTCP reveals the basis of recognition and sodium-driven transport of bile salts into the liver. Cell Res 32, 773–776 (2022). https://doi.org/10.1038/s41422-022-00680-4
- ↑ Qi X. and Li W. (2022). Unlocking the secrets to human NTCP structure. The Innovation 3(5), 100294. https://doi.org/10.1016/j.xinn.2022.100294
- ↑ Latorraca, N. R.; Fastman, N. M.; Venkatakrishnan, A. J.; Frommer, W. B.; Dror, R. O.; Feng, L. Mechanism of Substrate Translocation in an Alternating Access Transporter. Cell 2017, 169 (1), 96–107.
- ↑ 8.0 8.1 8.2 8.3 Asami, J., Kimura, K.T., Fujita-Fujiharu, Y. et al.Structure of the bile acid transporter and HBV receptor NTCP. Nature 606, 1021–1026 (2022). https://doi.org/10.1038/s41586-022-04845-4
- ↑ Grove, J.; Marsh, M. The Cell Biology of Receptor-Mediated Virus Entry. Journal of Cell Biology 2011, 195 (7), 1071–1082.
- ↑ 10.0 10.1 Herrscher C, Roingeard P, Blanchard E. Hepatitis B Virus Entry into Cells. Cells. 2020 Jun 18;9(6):1486. doi: 10.3390/cells9061486. PMID: 32570893; PMCID: PMC7349259.
PDB Files
Bile salts and sodium ions bound: 7zyi Open-pore NTCP: 7pqq Inward-facing NTCP: 7pqg
Student Contributors
- Isabelle White
- Lena Barko